"10.1371_journal.pmed.1000016","plos medicine","2009-01-20T00:00:00Z","Ian Ford; Vladimir Bezlyak; David J Stott; Naveed Sattar; Chris J Packard; Ivan Perry; Brendan M Buckley; J Wouter Jukema; Anton J M de Craen; Rudi G J Westendorp; James Shepherd","Robertson Centre for Biostatistics, University of Glasgow, Glasgow, Scotland; Academic Section of Geriatric Medicine, Cardiovascular Division, University of Glasgow, Glasgow, Scotland; Department of Vascular Biochemistry, North Glasgow Division, Greater Glasgow Health Board, Glasgow, Scotland; Department of Pharmacology and Therapeutics, Cork University Hospital, Wilton, Cork, Ireland; Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands; Section of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, The Netherlands","IF, DJS, CJP, IP, BMB, JWJ, AJMdC, RGJW, and JS designed the study. IF, VB, NS, BMB, JWJ, RGJW, and JS analyzed the data. BMB, JWJ, RGJW, and JS enrolled patients. IF, VB, DJS, NS, CJP, IP, BMB, JWJ, AJMdC, RGJW, and JS contributed to writing the paper.","JS reports that he was a consultant to Pfizer in the Treating to New Targets study and that he has been a speakers bureau member for AstraZeneca and Pfizer.","2009","01","Ian Ford","IF",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
